Two brothers, both physicians, had an idea to take the best part of a surgically implanted nerve stimulation product and to provide it to users in a way that was entirely non-invasive. Drs. Richard and Daniel Cartledge formed NERVANA LLC, including a team of multi-disciplinary medical and intellectual property experts and engineers to make that dream a reality. The team created NERVANA – a breakthrough wearable consumer product that accesses the Vagus nerve without surgery or percutaneous action and does so in harmony with recorded and live music.
Dr. Richard Cartledge,MD
Co-Founder, Director and CEO
Fellowship trained in cardiovascular surgery from New York Hospital/Weill Cornell Medical Center and in thoracic surgical oncology from Memorial Sloan Kettering, Dr. Richard Cartledge received his medical degree from the Medical College of Pennsylvania and a Bachelor of Science degree in mechanical engineering at Lehigh University. Dr. Richard Cartledge has over 20 years of experience in inventing, designing and manufacturing cutting edge medical devices and currently holds over 80 issued and pending patents. His inventions include the ThermaCor 1200 which is used in major trauma centers around the world, as well a heart valve that is installed with a computer activated catheter which he sold to Edwards Lifesciences corporation in the last two years.
Vincent C. Manopoli
Mr. Manopoli has worked as a principal and consultant to startups and turnaround businesses for the past 30+ years. He has worked in a variety of capacities including CEO COO and managing partner. He has experience in a variety of sectors from software to pharmaceuticals to medical devices and hospitals. Most recently he has worked in the death care industry and was the managing member for a $250M bankruptcy buyout and breakup.
Warren S. Orlando
Chairman of the Board
Mr. Orlando has a Bachelor of Science in Economics from St. Peters College and a Masters in Banking from Stonier School of Banking at Rutgers University. He has over 50 years of business experience including being founder, Chairman, and Chief Executive officer of two financial services companies. He grew these companies organically, as well as through 23 acquisitions. He raised over $100 million in private equity and brought both companies through IPO and secondary offerings, ultimately selling both companies to substantial returns to the shareholders.
Ami Brannon, RN
Co-Founder and Director
Mrs. Brannon has a Bachelor of Science in Nursing and a Bachelor of Science in Psychology, with a minor in health, both from the University of Central Florida. Brannon has over 20 years of hospital-based healthcare experience, including over 10 years in hospital administration.
Dr. Daniel Cartledge, MD
Co-Founder and Director
Dr. Daniel Cartledge received his undergraduate degree from Lehigh University and his Medical Degree from University of Saint Eustatius School of Medicine. He is double-board-certified in Pain Management and Physical Medicine & Rehabilitation. Dr. Cartledge specializes in interventional pain medicine and is an expert in neuro-electrical therapies to treat patients with chronic pain. Dr. Daniel Cartledge has served the South Florida market for over 10 years.
John Marino, CPA
President and Director
Mr. Marino has a Bachelor of Business in accounting from Stetson University. He has been the CFO and or President of a number of startup companies. He has been involved in over $200 million in private equity and debt fundings and brought three companies through the IPO and secondary offerings process. Mr. Marino has managed, negotiated and integrated 26 acquisitions and negotiated the sale of two public companies, delivering substantial returns to their stakeholders.
Kermit Arthur Falk
Director of Engineering
Mr. Falk has a Bachelor of Science in Mechanical Engineering from Georgia Tech and a Master of Science in Materials Science & Engineering from Johns Hopkins University. Prior to joining the Neuvana team, he worked in the nanotechnology field for a startup company. He successfully completed an ARPA•e project that demonstrated membrane-based dehumidification and was subsequently awarded funding for a Department of Defense chiller project. Mr. Falk has experience developing technology at both the Research & Development and commercially available levels.